- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.38%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 21 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Growth Option | 28.64% | 0.38% | 0.75% | 3.69% | 10.73% | 25.21% | - | - | - | - |
| SBI MNC FUND - REGULAR PLAN -GROWTH | 15.78% | -0.12% | -0.47% | -1.56% | 5.03% | 12.7% | 7.12% | 7.63% | 13.32% | 10.85% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 25.27% | 0.72% | 0.83% | 2.27% | 10.65% | 20.3% | 23.74% | 17.72% | 24.67% | 13.63% |
| SBI COMMA Fund - REGULAR PLAN - Growth | 4.73% | -0.6% | -1.23% | -1.24% | 0.25% | 8.38% | 15.47% | 10.36% | 18.85% | 14.59% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -5.48% | -0.07% | -0.01% | -3.53% | -1.06% | -3.77% | 8.02% | 7.29% | 11.93% | 10.74% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -0.39% | 0.04% | -0.68% | -2.49% | -4.34% | 0.65% | 12.68% | 15.14% | 18.55% | 14.41% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | 50.48% | 0.54% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.12% | -1.48% | -4.75% | 6.9% | -4.45% | 7.74% | 5% | 6.5% | 3.5% | 3.71% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 17.55% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.53% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.47% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.66% | |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.14% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.82% | |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 4.70% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.67% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.64% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.67% | |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 3.58% | |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.56% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.40% | |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.22% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 3.05% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.79% | |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 2.70% | |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% | |
| Jupiter Life Line Hospitals Limited | (INE682M01020) | Healthcare Services | 2.45% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.28% | |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 2.25% | |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.23% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.14% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.10% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.01% | |
| Dr Reddys Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.92% | |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.89% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.62% | |
| Rubicon Research Limited | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 1.61% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 1.58% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.42% | |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.28% | |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 1.25% | |
| CORONA REMEDIES LIMITED | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 1.24% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.07% | |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.01% | |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 0.65% | |
| Novartis India Ltd. | NOVARTIND (INE234A01025) | Pharmaceuticals & Biotechnology | 0.51% | |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.47% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.36% |
Portfolio data is as on date 31 July, 2026
NAV history
HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 21 September, 2026 | 22.101 | 0.38% |
| 18 September, 2026 | 22.017 | 1.14% |
| 17 September, 2026 | 21.768 | 1.51% |
| 16 September, 2026 | 21.444 | -0.38% |
| 15 September, 2026 | 21.525 | -1.87% |
| 11 September, 2026 | 21.936 | -0.44% |
| 10 September, 2026 | 22.033 | 0.28% |
| 9 September, 2026 | 21.971 | 0.25% |
| 8 September, 2026 | 21.916 | 0.92% |
| 7 September, 2026 | 21.717 | 0.34% |
| 4 September, 2026 | 21.643 | -0.38% |
| 3 September, 2026 | 21.725 | 0.24% |
| 2 September, 2026 | 21.673 | 0.08% |
| 1 September, 2026 | 21.656 | -0.89% |
| 31 August, 2026 | 21.85 | 0.47% |
| 28 August, 2026 | 21.748 | -0.05% |
| 27 August, 2026 | 21.758 | 0.57% |
| 26 August, 2026 | 21.634 | 0.64% |
| 25 August, 2026 | 21.496 | 0.68% |
| 24 August, 2026 | 21.35 | 0.16% |
| 21 August, 2026 | 21.315 | -0.19% |
| 20 August, 2026 | 21.355 | -0.06% |
| 19 August, 2026 | 21.368 | -0.85% |
| 18 August, 2026 | 21.552 | 0.43% |
| 17 August, 2026 | 21.459 | 0.2% |
| 14 August, 2026 | 21.417 | -0.04% |
| 13 August, 2026 | 21.425 | -0.06% |
| 12 August, 2026 | 21.438 | -0.87% |
| 11 August, 2026 | 21.626 | 0.68% |
| 10 August, 2026 | 21.479 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 22.101 as on 21 September, 2026.What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 28.64% as on 21 September, 2026.What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 25.21% as on 21 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option?
HDFC Pharma and Healthcare Fund - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.